New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with ...

Kairos Pharma has signed a binding agreement to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics.

While some chief executives have left for personal reasons, others have been ousted amid poor company performance.

OSE will now pivot to focus on late-stage pipeline development of its cancer vaccine, Tedopi and its anti-inflammatory drug, lusvertikimab.

US-based biotechnology company Rallybio has entered a definitive agreement to acquire Candid Therapeutics through a merger transaction.

Both Novo and obesity market rival Eli Lilly have outlaid significant funds to ensure future demand for oral weight loss drugs is met.

If approved, Moderna's mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across ...

BioMarin Pharmaceutical has received FDA approval for its sBLA for Palynziq’s use in adolescents aged 12 years and above with ...

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...

This deal adds two more siRNA candidates to GSK’s pipeline, which is expanding as the company looks to offset the impact of ...

The organised crime group were selling unlicensed weight loss-substances online, using social media to market products.

Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos for FOP.